Literature DB >> 24308275

The relationship between neurotrophins and bipolar disorder.

Renrong Wu1, Jinbo Fan, Jingping Zhao, Joseph R Calabrese, Keming Gao.   

Abstract

Relationship between neurotrophins, especially brain-derived neurotrophic factor (BDNF) and bipolar disorder (BPD) has been widely investigated, but results have been inconsistent. BDNF polymorphism may be associated with the susceptibility to subtype BPD such as rapid cycling BPD or early onset BPD. Met allele carriers of Val66Met of BDNF gene had smaller gray matter (GM) in both patients and healthy controls, but bipolar patients carrying Met allele had better response to lithium treatment. Decreased serum/plasma BDNF levels were observed at different mood states. BDNF may interact with other systems to execute its neuroprotective effects. Overall data suggest that neurotrophins may be involved in the pathogenesis of BPD and treatment response, but the magnitude of their role needs further investigation with large sample size studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24308275     DOI: 10.1586/14737175.2014.863709

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  13 in total

Review 1.  The role of DNA methylation in the pathophysiology and treatment of bipolar disorder.

Authors:  Gabriel R Fries; Qiongzhen Li; Blake McAlpin; Theo Rein; Consuelo Walss-Bass; Jair C Soares; Joao Quevedo
Journal:  Neurosci Biobehav Rev       Date:  2016-06-18       Impact factor: 8.989

2.  Protein Biomarkers in Monocytes and CD4+ Lymphocytes for Predicting Lithium Treatment Response of Bipolar Disorder: a Feasibility Study with Tyramine-Based Signal-Amplified Flow Cytometry.

Authors:  Keming Gao; Marzieh Ayati; Mehmet Koyuturk; Joseph R Calabrese; Stephen J Ganocy; Nicholas M Kaye; Hillard M Lazarus; Eric Christian; David Kaplan
Journal:  Psychopharmacol Bull       Date:  2022-02-25

3.  Imipramine Can Be Effective on Depressive-Like Behaviors, but Not on Neurotrophic Factor Levels in an Animal Model for Bipolar Disorder Induced by Ouabain.

Authors:  Taise Possamai-Della; Gustavo C Dal-Pont; Wilson R Resende; Jorge M Aguiar-Geraldo; Jefté Peper-Nascimento; João Quevedo; Samira S Valvassori
Journal:  Mol Neurobiol       Date:  2022-09-19       Impact factor: 5.682

Review 4.  The genetics of early-onset bipolar disorder: A systematic review.

Authors:  Kevin P Kennedy; Kathryn R Cullen; Colin G DeYoung; Bonnie Klimes-Dougan
Journal:  J Affect Disord       Date:  2015-05-15       Impact factor: 4.839

Review 5.  A new avenue for lithium: intervention in traumatic brain injury.

Authors:  Peter R Leeds; Fengshan Yu; Zhifei Wang; Chi-Tso Chiu; Yumin Zhang; Yan Leng; Gabriel R Linares; De-Maw Chuang
Journal:  ACS Chem Neurosci       Date:  2014-04-11       Impact factor: 4.418

Review 6.  Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis.

Authors:  Zuowei Wang; Zezhi Li; Keming Gao; Yiru Fang
Journal:  BMC Psychiatry       Date:  2014-12-24       Impact factor: 3.630

7.  Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins.

Authors:  Tushar Dwivedi; Hui Zhang
Journal:  Front Neurosci       Date:  2015-01-14       Impact factor: 4.677

8.  Circuits Regulating Pleasure and Happiness in Bipolar Disorder.

Authors:  Anton J M Loonen; Ralph W Kupka; Svetlana A Ivanova
Journal:  Front Neural Circuits       Date:  2017-05-22       Impact factor: 3.492

9.  Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population.

Authors:  Mirna Edith Morales-Marín; Alma Delia Genis-Mendoza; Carlos Alfonso Tovilla-Zarate; Nuria Lanzagorta; Michael Escamilla; Humberto Nicolini
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-25       Impact factor: 2.570

Review 10.  The evolutionary old forebrain as site of action to develop new psychotropic drugs.

Authors:  Anton Jm Loonen; Svetlana A Ivanova
Journal:  J Psychopharmacol       Date:  2018-09-26       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.